Table 1 shows that low KLF4 expression was associated with many clinical phenotypes, such as vascular invasion (***P <0.001), high alpha-fetoprotein level (*P = 0.012), and advanced Barcelona Clinic Liver Cancer (BCLC) stage (**P = 0.002). Here, KLF4 is linked to liver cancer.